From the Columbia Management Quantitative Strategies Equity Research Group 10-year timeline: Four periods of correlations and alpha 2003–2013 A: The pre-crisis period — Prior to the financial crisis, intrastock correlations were the lowest in the last 10 years, and for most of this time alpha was positive. B: The financial crisis — Unsurprisingly, alpha was
Higher-yielding equities underperformed the market last year raising questions about whether dividend investing remains an attractive strategy. Even if rates continue a long-term increase from current levels, we expect that equities sensitivity to rising rates will decline. We believe the drivers that have resulted in historical stock market outperformance from high-yielding equities remain intact. By
The markets have rewarded U.S. corporations that have embraced a discipline of strict cost oversight and a rigorous focus on returning capital to shareholders. We strongly favor such discipline unless it ends up crowding out reinvestment for innovation and profitable revenue growth. From the bare bones levels of the post-crisis period, it is encouraging to
Overuse of antibiotics has led to new classes of “super bugs” that are resistant to current or traditional antibiotic treatments. Legislative and economic incentives are driving innovation and adoption of new technologies in the antibiotic resistance category across the investable healthcare spectrum. We anticipate increased new drug development and improvements in the identification and treatment
The expected real return on most “safe haven” assets is currently negative. Risk seeking behavior could result in a bubble encompassing all risky assets. While current indicators support a pro risk stance, we are prepared to change our positioning as market conditions dictate. There is a great deal of discussion currently about the likely emergence
Risk Parity represents a significant advance in asset allocation, but we don’t believe that there is a single perfect policy portfolio. While Risk Parity works well in neutral markets, we don’t think it is the best policy under bearish, bullish or highly bullish market conditions. We believe that a policy function that rotates among four
Source: Columbia Management Investment Advisers, LLC, April 17, 2014. Individual asset class exposure in managed products may differ from the graphic above. Not all products are traded at quarter end, and performance can alter weights when viewed on a quarter-over-quarter basis.